Ashley Berger
Medical · Jacksonville, FLNPI 1699217463
Payments from drug & device makers
Across 58 payments — averaging $22.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$286
- Novartis$130
- Johnson & Johnson$118
- Daiichi Sankyo Inc.$108
- Ipsen Biopharmaceuticals, Inc$104
- AstraZeneca$94
- plus $443 from 17 others
What the payments were for
- Food & beverage$94373%
- Education$34127%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 9 | $286 |
| Novartis | 9 | $130 |
| Johnson & Johnson | 2 | $118 |
| Daiichi Sankyo Inc. | 6 | $108 |
| Ipsen Biopharmaceuticals, Inc | 2 | $104 |
| AstraZeneca(2 entities) | 3 | $94 |
| Pfizer | 5 | $77 |
| Eisai Inc. | 3 | $56 |
| G1 Therapeutics, Inc. | 2 | $36 |
| Bayer | 2 | $30 |
| AVEO Pharmaceuticals, Inc. | 2 | $26 |
| Sanofi | 2 | $25 |
| Fennec Pharmaceuticals, Inc. | 1 | $24 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
| Immunocore Limited | 1 | $22 |
| Acrotech Biopharma Inc. | 1 | $21 |
| Morphosys, US Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| AbbVie | 1 | $15 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $13 |
| GSK | 1 | $13 |
| Global Blood Therapeutics, Inc. | 1 | $12 |
How this compares
$1,284 in reported general payments places this provider in the 60th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SprycelDasatinib | 13 | $241,428 |
| IbrancePalbociclib | 11 | $172,081 |
| EliquisApixaban | 36 | $31,623 |
| XareltoRivaroxaban | 32 | $18,933 |
| Letrozole | 13 | $335 |
| Anastrozole | 12 | $235 |
| Levothyroxine Sodium | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerIbrance, Eliquis | $77 | $203,70447 claims |
| Johnson & JohnsonXarelto | $118 | $18,93332 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,031 medical providers in Florida.
Other medical in Jacksonville
- Eric PonderJacksonville$67K
- Kristen DixonJacksonville$54K
- Amanda MichaudJacksonville$45K
- Paul DuffJacksonville$35K
- Ina SansonJacksonville$15K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.